APO Research
Talk to an analyst

APO RESEARCH · REPORT

Combination Vaccine

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Combination Vaccine Industry Growth and Trends Forecast to 2032

22 December 202598 pages

Choose your research edition.

Industry ResearchCombination Vaccine Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Combination Vaccine Industry Growth and Trends Forecast to 203298 pages · $3,450 USDMarket StructureGlobal Combination Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032186 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Combination Vaccine Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Combination Vaccine Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Combination Vaccine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Combination Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Combination Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Combination Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Combination Vaccine include GSK, Merck, Pfizer, Serum Institute of India, Sanofi Pasteur MSD, Sanofi Pasteur, CNBG and Biokangtai, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Combination Vaccine market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Combination Vaccine market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Combination Vaccine market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Combination Vaccine.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Combination Vaccine market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Combination Vaccine Market by Company

GSK

Merck

Pfizer

Serum Institute of India

Sanofi Pasteur MSD

Sanofi Pasteur

CNBG

Biokangtai

Combination Vaccine Segment by Type

5 Combination

4 Combination

3 Combination

Other

Combination Vaccine Segment by Application

Adults

Children

Combination Vaccine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Combination Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Combination Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Combination Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Combination Vaccine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Combination Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 5 Combination Table 2. Major Company of 4 Combination Table 3. Major Company of 3 Combination Table 4. Major Company of Other Table 5. Global Combination Vaccine Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Combination Vaccine Sales by Type (2021-2026) & (k units) Table 7. Global Combination Vaccine Sales Market Share in Volume by Type (2021-2026) Table 8. Global Combination Vaccine Sales by Type (2021-2026) & (US$ Million) Table 9. Global Combination Vaccine Sales Market Share in Value by Type (2021-2026) Table 10. Global Combination Vaccine Price by Type (2021-2026) & (US$/unit) Table 11. Global Combination Vaccine Sales by Type (2027-2032) & (k units) Table 12. Global Combination Vaccine Sales Market Share in Volume by Type (2027-2032) Table 13. Global Combination Vaccine Sales by Type (2027-2032) & (US$ Million) Table 14. Global Combination Vaccine Sales Market Share in Value by Type (2027-2032) Table 15. Global Combination Vaccine Price by Type (2027-2032) & (US$/unit) Table 16. North America Combination Vaccine Sales by Type (2021-2026) & (k units) Table 17. North America Combination Vaccine Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Combination Vaccine Sales by Type (2021-2026) & (k units) Table 19. Europe Combination Vaccine Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Combination Vaccine Sales by Type (2021-2026) & (k units) Table 21. Asia-Pacific Combination Vaccine Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Combination Vaccine Sales by Type (2021-2026) & (k units) Table 23. Latin America Combination Vaccine Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Combination Vaccine Sales by Type (2021-2026) & (k units) Table 25. Middle East and Africa Combination Vaccine Sales by Type (2021-2026) & (US$ Million) Table 26. Combination Vaccine Industry Trends Table 27. Combination Vaccine Industry Drivers Table 28. Combination Vaccine Industry Opportunities and Challenges Table 29. Combination Vaccine Industry Restraints Table 30. Global Combination Vaccine Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Combination Vaccine Revenue Market Share by Company (2021-2026) Table 32. Global Combination Vaccine Sales by Company (2021-2026) & (k units) Table 33. Global Combination Vaccine Sales Share by Company (2021-2026) Table 34. Global Combination Vaccine Market Price by Company (2021-2026) & (US$/unit) Table 35. Global Combination Vaccine Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Combination Vaccine Major Company Production Sites and Headquarters Table 37. Global Combination Vaccine Company, Product Type & Application Table 38. Global Combination Vaccine Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Combination Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Combination Vaccine Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Combination Vaccine Sales by Region (2021-2026) & (k units) Table 43. Global Combination Vaccine Sales Market Share in Volume by Region (2021-2026) Table 44. Global Combination Vaccine Sales by Region (2021-2026) & (US$ Million) Table 45. Global Combination Vaccine Sales Market Share in Value by Region (2021-2026) Table 46. Global Combination Vaccine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 47. Global Combination Vaccine Sales by Region (2027-2032) & (k units) Table 48. Global Combination Vaccine Sales Market Share in Volume by Region (2027-2032) Table 49. Global Combination Vaccine Sales by Region (2027-2032) & (US$ Million) Table 50. Global Combination Vaccine Sales Market Share in Value by Region (2027-2032) Table 51. Global Combination Vaccine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 52. Global Combination Vaccine Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Combination Vaccine Sales by Application (2021-2026) & (k units) Table 54. Global Combination Vaccine Sales Market Share in Volume by Application (2021-2026) Table 55. Global Combination Vaccine Sales by Application (2021-2026) & (US$ Million) Table 56. Global Combination Vaccine Sales Market Share in Value by Application (2021-2026) Table 57. Global Combination Vaccine Price by Application (2021-2026) & (US$/unit) Table 58. Global Combination Vaccine Sales by Application (2027-2032) & (k units) Table 59. Global Combination Vaccine Sales Market Share in Volume by Application (2027-2032) Table 60. Global Combination Vaccine Sales by Application (2027-2032) & (US$ Million) Table 61. Global Combination Vaccine Sales Market Share in Value by Application (2027-2032) Table 62. Global Combination Vaccine Price by Application (2027-2032) & (US$/unit) Table 63. North America Combination Vaccine Sales by Application (2021-2026) & (k units) Table 64. North America Combination Vaccine Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Combination Vaccine Sales by Application (2021-2026) & (k units) Table 66. Europe Combination Vaccine Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Combination Vaccine Sales by Application (2021-2026) & (k units) Table 68. Asia-Pacific Combination Vaccine Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Combination Vaccine Sales by Application (2021-2026) & (k units) Table 70. Latin America Combination Vaccine Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Combination Vaccine Sales by Application (2021-2026) & (k units) Table 72. Middle East and Africa Combination Vaccine Sales by Application (2021-2026) & (US$ Million) Table 73. GSK Company Information Table 74. GSK Business Overview Table 75. GSK Combination Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 76. GSK Combination Vaccine Product Portfolio Table 77. GSK Recent Development Table 78. Merck Company Information Table 79. Merck Business Overview Table 80. Merck Combination Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 81. Merck Combination Vaccine Product Portfolio Table 82. Merck Recent Development Table 83. Pfizer Company Information Table 84. Pfizer Business Overview Table 85. Pfizer Combination Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 86. Pfizer Combination Vaccine Product Portfolio Table 87. Pfizer Recent Development Table 88. Serum Institute of India Company Information Table 89. Serum Institute of India Business Overview Table 90. Serum Institute of India Combination Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 91. Serum Institute of India Combination Vaccine Product Portfolio Table 92. Serum Institute of India Recent Development Table 93. Sanofi Pasteur MSD Company Information Table 94. Sanofi Pasteur MSD Business Overview Table 95. Sanofi Pasteur MSD Combination Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 96. Sanofi Pasteur MSD Combination Vaccine Product Portfolio Table 97. Sanofi Pasteur MSD Recent Development Table 98. Sanofi Pasteur Company Information Table 99. Sanofi Pasteur Business Overview Table 100. Sanofi Pasteur Combination Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 101. Sanofi Pasteur Combination Vaccine Product Portfolio Table 102. Sanofi Pasteur Recent Development Table 103. CNBG Company Information Table 104. CNBG Business Overview Table 105. CNBG Combination Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 106. CNBG Combination Vaccine Product Portfolio Table 107. CNBG Recent Development Table 108. Biokangtai Company Information Table 109. Biokangtai Business Overview Table 110. Biokangtai Combination Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 111. Biokangtai Combination Vaccine Product Portfolio Table 112. Biokangtai Recent Development Table 113. North America Combination Vaccine Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 114. North America Combination Vaccine Sales by Country (2021-2026) & (k units) Table 115. North America Combination Vaccine Sales Market Share by Country (2021-2026) Table 116. North America Combination Vaccine Sales Forecast by Country (2027-2032) & (k units) Table 117. North America Combination Vaccine Sales Market Share Forecast by Country (2027-2032) Table 118. North America Combination Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 119. North America Combination Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 120. North America Combination Vaccine Market Share by Country (2021-2026) Table 121. North America Combination Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 122. North America Combination Vaccine Market Share Forecast by Country (2027-2032) Table 123. Europe Combination Vaccine Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 124. Europe Combination Vaccine Sales by Country (2021-2026) & (k units) Table 125. Europe Combination Vaccine Sales Market Share by Country (2021-2026) Table 126. Europe Combination Vaccine Sales Forecast by Country (2027-2032) & (k units) Table 127. Europe Combination Vaccine Sales Market Share Forecast by Country (2027-2032) Table 128. Europe Combination Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 129. Europe Combination Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 130. Europe Combination Vaccine Market Share by Country (2021-2026) Table 131. Europe Combination Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 132. Europe Combination Vaccine Market Share Forecast by Country (2027-2032) Table 133. Asia-Pacific Combination Vaccine Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 134. Asia-Pacific Combination Vaccine Sales by Country (2021-2026) & (k units) Table 135. Asia-Pacific Combination Vaccine Sales Market Share by Country (2021-2026) Table 136. Asia-Pacific Combination Vaccine Sales Forecast by Country (2027-2032) & (k units) Table 137. Asia-Pacific Combination Vaccine Sales Market Share Forecast by Country (2027-2032) Table 138. Asia-Pacific Combination Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. Asia-Pacific Combination Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 140. Asia-Pacific Combination Vaccine Market Share by Country (2021-2026) Table 141. Asia-Pacific Combination Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. Asia-Pacific Combination Vaccine Market Share Forecast by Country (2027-2032) Table 143. Latin America Combination Vaccine Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 144. Latin America Combination Vaccine Sales by Country (2021-2026) & (k units) Table 145. Latin America Combination Vaccine Sales Market Share by Country (2021-2026) Table 146. Latin America Combination Vaccine Sales Forecast by Country (2027-2032) & (k units) Table 147. Latin America Combination Vaccine Sales Market Share Forecast by Country (2027-2032) Table 148. Latin America Combination Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. Latin America Combination Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 150. Latin America Combination Vaccine Market Share by Country (2021-2026) Table 151. Latin America Combination Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. Latin America Combination Vaccine Market Share Forecast by Country (2027-2032) Table 153. Middle East and Africa Combination Vaccine Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 154. Middle East and Africa Combination Vaccine Sales by Country (2021-2026) & (k units) Table 155. Middle East and Africa Combination Vaccine Sales Market Share by Country (2021-2026) Table 156. Middle East and Africa Combination Vaccine Sales Forecast by Country (2027-2032) & (k units) Table 157. Middle East and Africa Combination Vaccine Sales Market Share Forecast by Country (2027-2032) Table 158. Middle East and Africa Combination Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 159. Middle East and Africa Combination Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 160. Middle East and Africa Combination Vaccine Market Share by Country (2021-2026) Table 161. Middle East and Africa Combination Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 162. Middle East and Africa Combination Vaccine Market Share Forecast by Country (2027-2032) Table 163. Key Raw Materials Table 164. Raw Materials Key Suppliers Table 165. Combination Vaccine Distributors List Table 166. Combination Vaccine Customers List Table 167. Research Programs/Design for This Report Table 168. Authors List of This Report Table 169. Secondary Sources Table 170. Primary Sources List of Figures Figure 1. Combination Vaccine Image Figure 2. Global Combination Vaccine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Combination Vaccine Market Size (2021-2032) & (US$ Million) Figure 4. Global Combination Vaccine Sales (2021-2032) & (k units) Figure 5. 5 Combination Image Figure 6. Global 5 Combination Sales YoY Growth (2021-2032) & (k units) Figure 7. 4 Combination Image Figure 8. Global 4 Combination Sales YoY Growth (2021-2032) & (k units) Figure 9. 3 Combination Image Figure 10. Global 3 Combination Sales YoY Growth (2021-2032) & (k units) Figure 11. Other Image Figure 12. Global Other Sales YoY Growth (2021-2032) & (k units) Figure 13. Global Combination Vaccine Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Combination Vaccine Market Share by Type 2025 VS 2032 Figure 15. North America Combination Vaccine Sales Market Share in Volume by Type in 2025 Figure 16. North America Combination Vaccine Sales Market Share in Value by Type in 2025 Figure 17. Europe Combination Vaccine Sales Market Share in Volume by Type in 2025 Figure 18. Europe Combination Vaccine Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Combination Vaccine Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Combination Vaccine Sales Market Share in Value by Type in 2025 Figure 21. Latin America Combination Vaccine Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Combination Vaccine Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Combination Vaccine Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Combination Vaccine Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Combination Vaccine Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Adults Image Figure 28. Global Adults Sales YoY Growth (2021-2032) & (k units) Figure 29. Children Image Figure 30. Global Children Sales YoY Growth (2021-2032) & (k units) Figure 31. Global Combination Vaccine Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Combination Vaccine Market Share by Application 2025 VS 2032 Figure 33. North America Combination Vaccine Sales Market Share in Volume by Application in 2025 Figure 34. North America Combination Vaccine Sales Market Share in Value by Application in 2025 Figure 35. Europe Combination Vaccine Sales Market Share in Volume by Application in 2025 Figure 36. Europe Combination Vaccine Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Combination Vaccine Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Combination Vaccine Sales Market Share in Value by Application in 2025 Figure 39. Latin America Combination Vaccine Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Combination Vaccine Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Combination Vaccine Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Combination Vaccine Sales Market Share in Value by Application in 2025 Figure 43. North America Combination Vaccine Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 44. North America Combination Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Combination Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Combination Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Combination Vaccine Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 48. Europe Combination Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Combination Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Combination Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Combination Vaccine Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 52. Asia-Pacific Combination Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Combination Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Combination Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Combination Vaccine Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 56. Latin America Combination Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Combination Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Combination Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Combination Vaccine Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 60. Middle East and Africa Combination Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Combination Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Combination Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Combination Vaccine Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Combination Vaccine Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • 5 Combination
  • 4 Combination
  • 3 Combination
  • Other
Applications
  • Adults
  • Children
Companies covered
  • GSK
  • Merck
  • Pfizer
  • Serum Institute of India
  • Sanofi Pasteur MSD
  • Sanofi Pasteur
  • CNBG
  • Biokangtai

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Combination Vaccine Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Combination Vaccine Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Combination Vaccine Market by Type
  6. 1.3.1 5 Combination
  7. 1.3.2 4 Combination
  8. 1.3.3 3 Combination
  9. 1.3.4 Other
  10. 1.4 Global Combination Vaccine Market Size by Type
  11. 1.4.1 Global Combination Vaccine Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Combination Vaccine Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Combination Vaccine Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Combination Vaccine Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Combination Vaccine Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Combination Vaccine Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Combination Vaccine Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Combination Vaccine Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Combination Vaccine Industry Trends
  2. 2.2 Combination Vaccine Industry Drivers
  3. 2.3 Combination Vaccine Industry Opportunities and Challenges
  4. 2.4 Combination Vaccine Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Combination Vaccine Revenue (2021-2026)
  2. 3.2 Global Top Players by Combination Vaccine Sales (2021-2026)
  3. 3.3 Global Top Players by Combination Vaccine Price (2021-2026)
  4. 3.4 Global Combination Vaccine Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Combination Vaccine Major Company Production Sites & Headquarters
  6. 3.6 Global Combination Vaccine Company, Product Type & Application
  7. 3.7 Global Combination Vaccine Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Combination Vaccine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Combination Vaccine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Combination Vaccine Tier 1, Tier 2, and Tier 3
4 Combination Vaccine Regional Status and Outlook
  1. 4.1 Global Combination Vaccine Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Combination Vaccine Historic Market Size by Region
  3. 4.2.1 Global Combination Vaccine Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Combination Vaccine Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Combination Vaccine Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Combination Vaccine Forecasted Market Size by Region
  7. 4.3.1 Global Combination Vaccine Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Combination Vaccine Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Combination Vaccine Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Combination Vaccine by Application
  1. 5.1 Combination Vaccine Market by Application
  2. 5.1.1 Adults
  3. 5.1.2 Children
  4. 5.2 Global Combination Vaccine Market Size by Application
  5. 5.2.1 Global Combination Vaccine Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Combination Vaccine Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Combination Vaccine Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Combination Vaccine Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Combination Vaccine Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Combination Vaccine Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Combination Vaccine Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Combination Vaccine Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 GSK
  2. 6.1.1 GSK Company Information
  3. 6.1.2 GSK Business Overview
  4. 6.1.3 GSK Combination Vaccine Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 GSK Combination Vaccine Product Portfolio
  6. 6.1.5 GSK Recent Developments
  7. 6.2 Merck
  8. 6.2.1 Merck Company Information
  9. 6.2.2 Merck Business Overview
  10. 6.2.3 Merck Combination Vaccine Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Merck Combination Vaccine Product Portfolio
  12. 6.2.5 Merck Recent Developments
  13. 6.3 Pfizer
  14. 6.3.1 Pfizer Company Information
  15. 6.3.2 Pfizer Business Overview
  16. 6.3.3 Pfizer Combination Vaccine Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Pfizer Combination Vaccine Product Portfolio
  18. 6.3.5 Pfizer Recent Developments
  19. 6.4 Serum Institute of India
  20. 6.4.1 Serum Institute of India Company Information
  21. 6.4.2 Serum Institute of India Business Overview
  22. 6.4.3 Serum Institute of India Combination Vaccine Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Serum Institute of India Combination Vaccine Product Portfolio
  24. 6.4.5 Serum Institute of India Recent Developments
  25. 6.5 Sanofi Pasteur MSD
  26. 6.5.1 Sanofi Pasteur MSD Company Information
  27. 6.5.2 Sanofi Pasteur MSD Business Overview
  28. 6.5.3 Sanofi Pasteur MSD Combination Vaccine Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Sanofi Pasteur MSD Combination Vaccine Product Portfolio
  30. 6.5.5 Sanofi Pasteur MSD Recent Developments
  31. 6.6 Sanofi Pasteur
  32. 6.6.1 Sanofi Pasteur Company Information
  33. 6.6.2 Sanofi Pasteur Business Overview
  34. 6.6.3 Sanofi Pasteur Combination Vaccine Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Sanofi Pasteur Combination Vaccine Product Portfolio
  36. 6.6.5 Sanofi Pasteur Recent Developments
  37. 6.7 CNBG
  38. 6.7.1 CNBG Company Information
  39. 6.7.2 CNBG Business Overview
  40. 6.7.3 CNBG Combination Vaccine Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 CNBG Combination Vaccine Product Portfolio
  42. 6.7.5 CNBG Recent Developments
  43. 6.8 Biokangtai
  44. 6.8.1 Biokangtai Company Information
  45. 6.8.2 Biokangtai Business Overview
  46. 6.8.3 Biokangtai Combination Vaccine Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Biokangtai Combination Vaccine Product Portfolio
  48. 6.8.5 Biokangtai Recent Developments
7 North America by Country
  1. 7.1 North America Combination Vaccine Sales by Country
  2. 7.1.1 North America Combination Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Combination Vaccine Sales by Country (2021-2026)
  4. 7.1.3 North America Combination Vaccine Sales Forecast by Country (2027-2032)
  5. 7.2 North America Combination Vaccine Market Size by Country
  6. 7.2.1 North America Combination Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Combination Vaccine Market Size by Country (2021-2026)
  8. 7.2.3 North America Combination Vaccine Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Combination Vaccine Sales by Country
  2. 8.1.1 Europe Combination Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Combination Vaccine Sales by Country (2021-2026)
  4. 8.1.3 Europe Combination Vaccine Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Combination Vaccine Market Size by Country
  6. 8.2.1 Europe Combination Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Combination Vaccine Market Size by Country (2021-2026)
  8. 8.2.3 Europe Combination Vaccine Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Combination Vaccine Sales by Country
  2. 9.1.1 Asia-Pacific Combination Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Combination Vaccine Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Combination Vaccine Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Combination Vaccine Market Size by Country
  6. 9.2.1 Asia-Pacific Combination Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Combination Vaccine Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Combination Vaccine Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Combination Vaccine Sales by Country
  2. 10.1.1 South America Combination Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Combination Vaccine Sales by Country (2021-2026)
  4. 10.1.3 South America Combination Vaccine Sales Forecast by Country (2027-2032)
  5. 10.2 South America Combination Vaccine Market Size by Country
  6. 10.2.1 South America Combination Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Combination Vaccine Market Size by Country (2021-2026)
  8. 10.2.3 South America Combination Vaccine Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Combination Vaccine Sales by Country
  2. 11.1.1 Middle East and Africa Combination Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Combination Vaccine Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Combination Vaccine Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Combination Vaccine Market Size by Country
  6. 11.2.1 Middle East and Africa Combination Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Combination Vaccine Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Combination Vaccine Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Combination Vaccine Value Chain Analysis
  2. 12.1.1 Combination Vaccine Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Combination Vaccine Production Mode & Process
  7. 12.2 Combination Vaccine Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Combination Vaccine Distributors
  10. 12.2.3 Combination Vaccine Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst